CIM
TMDX icon

CIM Investment Management’s Transmedics TMDX Stock Holding History

CIM Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,516
Closed -$211K – 290
2023
Q2 		$211K Buy
+2,516
New +$193K 0.07% 244

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

CIM Investment Management's TMDX Position: Q3 2023 in Review

CIM Investment Management sold out of Transmedics (TMDX) in Q3 2023, closing a stake of 2,516 shares — an estimated $211K sold.

CIM Investment Management first reported a position in TMDX in Q2 2023 and held it in 1 quarter. The position peaked at $211K in Q2 2023. 221 funds tracked by Wall St. Rank hold TMDX as of Q3 2023.

  • CIM Investment Management reported no remaining Transmedics position as of Q3 2023 after selling out during the quarter.
  • CIM Investment Management sold 2,516 Transmedics shares in Q3 2023, an estimated $211K.
  • CIM Investment Management first reported a position in Transmedics in Q2 2023 and held it in 1 quarter.
  • CIM Investment Management's Transmedics position peaked at $211K in Q2 2023.
  • 221 funds tracked by Wall St. Rank held Transmedics as of Q3 2023.

Based on CIM Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.